1 not yet recruiting. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Not yet recruiting 1 |
| Phase 2 | 1 | Not yet recruiting 1 |
Follow Adicet Therapeutics: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase 1/2 Trial of ADI-212 in mCRPC ADI-212, Fludarabine, Cyclophosphamide - Prostate Cancer Metastatic | Phase 1 / Phase 2 | Not yet recruiting | Adicet Therapeutics | 12 | 2026-09-01 | 2026-09-10 |
Cyclophosphamide (1) · fludarabine (1)
United States (1)